Clinical Scorecard: Exploring the Role of Social Genomics in Squamous Cell Carcinoma Outcomes: Distinguishing Genetic Factors from Environmental Influences
At a Glance
Category
Detail
Condition
Squamous Cell Carcinoma (SCCa)
Key Mechanisms
Social determinants of health (SDoH) influence tumor biology through stress-mediated pathways, epigenetic modifications, and altered gene expression.
Target Population
Patients with squamous cell carcinomas of the head and neck, esophagus, and lungs.
Care Setting
Oncology and public health settings addressing cancer disparities.
Key Highlights
SDoH significantly impact SCCa outcomes through biological mechanisms.
Chronic stress activates the HPA axis and sympathetic nervous system, leading to proinflammatory gene expression.
Distinct race- and neighborhood-specific DNAm patterns observed in SCCa.
Therapeutic strategies targeting biological mediators show variable efficacy.
Geospatial modeling may identify cancer risk patterns and therapeutic targets.
Guideline-Based Recommendations
Diagnosis
Consider social determinants of health when assessing SCCa outcomes.
Management
Explore therapeutic strategies that target epigenetic modifications and stress response pathways.
Monitoring & Follow-up
Monitor for disparities in access to cancer screening and treatment based on neighborhood deprivation.
Risks
Increased cancer incidence and poorer outcomes in socioeconomically distressed populations.
Patient & Prescribing Data
Patients from disadvantaged neighborhoods with SCCa.
Variable efficacy of β-adrenergic blockers, DNA methyltransferase inhibitors, and histone deacetylase inhibitors in SCCa.
Clinical Best Practices
Incorporate social context into tumor genomic analysis.
Utilize multi-omics data to inform personalized cancer prevention strategies.
